Atea Pharmaceuticals's total assets for Q4 2025 were $315.22M, a decrease of -8.09% from the previous quarter. AVIR total liabilities were $39.78M for the fiscal quarter, a 46.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.